ProQR Therapeutics (PRQR) Non-Current Assets (2013 - 2026)

ProQR Therapeutics (PRQR) has reported Non-Current Assets for 14 consecutive years, with $13.7 million the latest figure, recorded in Q1 2026.

• Quarterly Non-Current Assets fell 11.43% year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.0 million (down 12.81% YoY) and the FY2025 annual result came in at $14.4 million, down 10.51% from the prior year.
• Non-Current Assets retreated to $13.7 million in Q1 2026 per PRQR's latest filing, from $14.4 million in the prior quarter.
• Over the last five years, Non-Current Assets for PRQR reached as high as $20.5 million in Q2 2022 and fell as low as $13.7 million in Q1 2026.
• A 5-year average of $17.7 million and a median of $18.7 million in 2023 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets tumbled 99.98% — and 2024, when it gained 1.95%.
• Year by year, Non-Current Assets stood at $19.2 million in 2022, then climbed by 0.21% to $19.2 million in 2023, then dropped by 16.48% to $16.1 million in 2024, then retreated by 10.51% to $14.4 million in 2025, then retreated by 4.58% to $13.7 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $13.7 million, $14.4 million, and $14.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.